Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2019 12:15 ET | Source: Athersys, Inc.

Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

CLEVELAND, May 20, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced additional favorable data from its exploratory Phase 1/2 acute respiratory distress syndrome (ARDS) clinical...
May 14, 2019 06:00 ET | Source: Athersys, Inc.

Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Distress Syndrome

CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its clinical program evaluating MultiStem® cell therapy for the treatment of Acute Respiratory Distress...
May 08, 2019 16:05 ET | Source: Athersys, Inc.

Athersys Reports First Quarter 2019 Results

CLEVELAND, May 08, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2019. Highlights of the first quarter of 2019...
April 23, 2019 06:00 ET | Source: Athersys, Inc.

HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem® Treatment for Acute Respiratory Distress Syndrome

CLEVELAND, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its ONE-BRIDGE study...
April 15, 2019 10:00 ET | Source: Athersys, Inc.

Athersys to Host Investor Day in New York City

CLEVELAND, Ohio, April 15, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that the company will host an investor day on Tuesday, May 14, 2019. The event will focus on the...
April 10, 2019 14:00 ET | Source: Athersys, Inc.

Athersys to Host First Quarter Financial Results Call

CLEVELAND, April 10, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, May 8, 2019, and...
April 01, 2019 13:00 ET | Source: Athersys, Inc.

Athersys to Participate in Two Upcoming Healthcare Conferences

CLEVELAND, April 01, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the Company’s participation in two upcoming biotechnology and healthcare conferences. On April 4th,...
March 14, 2019 17:04 ET | Source: Athersys, Inc.

Athersys Announces Financial Results for Fourth Quarter and Full Year 2018

Substantial progress over the year, advancing programs andexpanding collaboration with HEALIOS K.K. Management to host conference call at 4:30 PM EST today CLEVELAND, March 14, 2019 (GLOBE...
February 14, 2019 08:00 ET | Source: Athersys, Inc.

Athersys to Host Year-End 2018 Financial Results Call

CLEVELAND, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, March 14, 2019, and...
January 23, 2019 06:00 ET | Source: Athersys, Inc.

Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)

CLEVELAND, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell...